And they have that rating on SNTS for over a week. The Zacks report dated 1/25 shows 4 strong buys from other brokers but where the difference is Zacks estimates SNTS losing (0.08) in 2013 and losing (0.04) in 2014. I have a modest long position with SNTS and I'am just going to hold that and not add any. These biotech companies can go all over the place but SNTS has had a good run which can result in a good pullback when you least expect it. Good Luck!
Passive bashing or indecision? How about telling it like it is! I got hard earned money tied up in this. I'am not the one who rated it a sell Zack did. You can check that out on the free part of their site. I pay for the premium Zacks so I get the detailed reports on any company. I don't understand why they rate it a sell but I follow them several times a day and they are never off by 4 rating steps so they must know something. On the other hand I'am not saying you're wrong I just don't know.